In this section of the page, you will find all the information you need to understand how UCB (UCB) dividends work. In addition, you will be able to consult the payment date, the ex-dividend date, the last day to be entitled to the payment, the money to be received per share, the yield and any other doubts that may arise.

Upcoming UCB dividend
Change(%)
-6.77%
Decrease
Next payment 1.24€
Next payment date May 2, 2024
Last payment 1.33€
Last payment date May 3, 2023
00 D 00 H 00 M 00 S
Ex-Dividend: 4/26/24
Estimated

UCB will distribute 1,24 euros per share in the form of a dividend on May 2, 2024.

The April 26, 2024 is the ex-dividend date. So if you wish to receive UCB dividends, you must buy one day before this date.

UCB distributed 1.33 euros per share in the form of a dividend on May 3, 2023.

UCB S.A., listed on the stock exchanges of Brussels, Frankfurt, Vienna, BATS EU, OTC market, London and TradeGate, recognized with the stock exchange symbol UCB, has a track record of more than twenty years paying dividends to its shareholders without suspensions, starting in 1999 and has remained stable and consistent to date.

The value of the amount delivered has been maintained in a very approximate range for several periods, being settled in a single annual installment, usually granted in the first days of May, reaching a yield of approximately 1.20%.

Payout Ratio UCB Dividends

UCB paid 7% of its net income in the last fiscal period as dividends.
Dividend payout ratio

The dividend payout ratio, also known as the payout ratio, is an essential indicator for assessing the stability of a company's dividends. This ratio shows what proportion of the company's net profit is used to pay dividends to shareholders.

Dividend payout ratio = Total dividends ÷ Net income

UCB's earnings (5,111,000,064.00€) are sufficient to cover the dividend payment. This payment represents 7% of the total net profit of UCB.
Dividend payout ratio
General recommendations

An appropriate payout ratio may vary depending on the industry, the company's growth stage and its financial health.

Payout Ratio

Dividend calendar of UCB

This is the Dividend Calendar of UCB in 2023.

Event Day
Last trading date April 25, 2024
Ex-Dividend (Ex-Date) April 26, 2024
Record date May 1, 2024
Date of payment May 2, 2024
Dividends schedule UCB
Data pending official confirmation from the company UCB (UCB).
Estimated
Estimation Policy

Our policy is based on extracting all the financial information available for each company so that our own algorithms weight this information, thus giving us a result as close as possible to the real data.

Source

Historical annual dividend yields of UCB

Over the past 5 years, UCB has steadily increased the annual dividend amount.
Increasing Dividends
Increasing Dividend Program

For a company to have growing dividends by our standards, the annual dividend amount must have increased steadily for at least the last 5 years.

Dividend yield

Dividend yield of UCB vs. the sector

UCB's dividend yield (1.78%) is above the sector average (1.71%).
Comparison with industry average
Comparison with industry average

The company's dividend yield is compared to the industry average to determine its positioning.

UCB's dividend yield is among the top 25% (1.71%) of the sector.
Evaluation with respect to competence.
Comparison with competitors

Imagine you have a list of dividend yields for different companies in an industry. If you look for the "top 25%% percentile", you will find a number. This number tells you that the top 25%% of the companies with the highest dividends have a yield higher than that number.

On the other hand, the "top 75%% percentile" shows you another number, which tells you that 75%% of the companies have a higher yield than that number, thus showing a more common and less high yield.

Dividend yield history in UCB

In the last 5 years, UCB's annual dividend amount has not fallen more than 10%.
Dividend stability
Dividend stability

For a company to have stable dividends by our standards, it is vital that it has not had an annual decline of more than 10% over the previous year.

Dividend history of UCB

In this table you can see the dividend history of UCB:

YearEx-DividendAmountTotal
2023
04/28/2023
1.33 €
1.33 €
2022
04/29/2022
1.3 €
1.3 €
2021
04/30/2021
1.27 €
1.27 €
2020
05/04/2020
1.24 €
1.24 €
2019
04/26/2019
1.21 €
1.21 €
2018
04/27/2018
1.18 €
1.18 €
2017
04/28/2017
1.15 €
1.15 €
2016
04/29/2016
1.1 €
1.1 €
2015
05/04/2015
1.06 €
1.06 €
2014
04/29/2014
1.04 €
1.04 €
2013
05/02/2013
1.02 €
1.02 €
2012
04/27/2012
1. €
1 €
2011
05/02/2011
0.98 €
0.98 €
2010
05/03/2010
04/30/2010
0.96 €
0.96 €
1.92 €
2009
05/05/2009
0.92 €
0.92 €
2008
04/28/2008
0.92 €
0.92 €
2007
04/30/2007
0.9 €
0.9 €
2006
06/16/2006
0.88 €
0.88 €
2005
06/17/2005
0.86 €
0.86 €
2004
06/11/2004
04/21/2004
0.82 €
0.5 €
1.32 €
2003
06/13/2003
04/15/2003
0.8 €
0.41 €
1.21 €
2002
06/14/2002
04/17/2002
0.76 €
0.38 €
1.14 €
2001
06/14/2001
0.64 €
0.64 €
2000
06/14/2000
0.5 €
0.5 €
Dividend history of UCB

UCB dividend capture strategy

Step 1: Buy UCB shares (UCB) one day before ex-dividend date
Date of purchase Apr 25, 2024
Next ex-dividend date Apr 26, 2024
Step 2: Sell UCB shares (UCB) when the price recovers.
Date of sale (estimated) N/A
Average price recovery N/A
Average return on cost N/A
The dividend capture strategy is based on historical UCB data. Past performance is no guarantee of future results.

Information about UCB

Full name UCB SA
Ticker UCB
Sector Health Care
Industry Biotechnology
Market Capitalization 14.08B €
ISIN N/A
Number of Employees 8,600
Address AllEe de la Recherche, 60, Brussels, 1070, Belgium
Phone 32 2 559 99 99
Website https://www.ucb.com
Description of the company

UCB S.A., a company dedicated to the health industry, specializing in the development of pharmaceutical products to treat serious, immunological and neurological diseases, with headquarters in Belgium, is present in 40 countries, with more than 8 thousand employees, registering 5.5 billion euros in sales in 2022.

It was founded in 1928 by Emmanuel Janssen, which was initially dedicated to the creation of industrial chemicals, being one of the first to distill ammonia from coal, also including a pharmaceutical laboratory, in 1950 created a research and development center where they produce key drugs for the company as Atarax, Piracetam or Nootropil and Zyrtec or cetirizine.

In 2002 they merged their previous activities and added others such as the creation of resins and additives, splitting the chemicals division in 2004, when they acquired the biotechnology company Celltech, in 2019 they bought Ra Pharma, a specialist in immunological diseases, and in 2022 they acquired Zogenix, remaining exclusively in the pharmaceutical sector.

The main products for which UCB is recognized are Atarax, Briviact, Nootropil, Zyrtec and Xyzal antihistamines, Keppra and Cimzia anticonvulsant drugs for the treatment of epilepsy, Vimpat an anticonvulsant, Atamet and Neupro used for Parkinson's disease.

Frequently asked questions about UCB dividends

UCB pays dividends on a Annual basis.

UCB is listed on the Bolsa de Bruselas and is part of the BEL20.

UCB has the Ticker or stock code UCB.

UCB belongs to the Health Care sector and the Biotechnology industry.

The CEO of UCB in 2023 is Mr. Jean-Christophe Tellier.

At this moment, the value of a UCB share is 74.22€.

UCB has a growing dividend program. In the last 5 years, dividends have been at least equal to or higher than the previous year.

UCB Forum

Check the latest comments and participate in the live chat on UCB stocks (UCB).
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments